Maktaba

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Evaluating the Diagnostic Role of the Testosterone-to-Prostate-Specific Antigen Ratio in Pre-Biopsy Risk Stratification of Prostate Cancer.

Authors : Tsakaldimis, Georgios¹ (AUTHOR) ; Diamantidis, Dimitrios^1,2 (AUTHOR); Lailisidis, Stavros¹ (AUTHOR)

Source: Journal of Clinical Medicine. May2025, Vol. 14 Issue 9, p3022. 13p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting.

Authors : Pedrani, Martino^1,2 (AUTHOR); Salfi, Giuseppe^1,2,3 (AUTHOR); Merler, Sara^1,3,4,5 (AUTHOR)

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 11, p5309. 16p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Online adaptive stereotactic body radiotherapy for localized prostate cancer in patients with lower urinary tract symptoms and/or prostate hyperplasia (X-SMILE).

Authors : Kroese, Tiuri¹ (AUTHOR) ; Andratschke, Nicolaus¹ (AUTHOR); Belka, Claus² (AUTHOR)

Source: Radiation Oncology. 5/28/2025, Vol. 20 Issue 1, p1-11. 11p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications.

Authors : Vescovo, Mariavittoria¹ (AUTHOR) ; Raspollini, Maria Rosaria² (AUTHOR); Nibid, Lorenzo^1,3 (AUTHOR)

Source: Cancers. May2025, Vol. 17 Issue 10, p1705. 12p.

Record details

Read Online Read More Add to Saved list

Academic Journal

PSMA PET as a Tool for Active Surveillance of Prostate Cancer—Where Are We at?

Authors : Carll, Jonathon^1,2,3 (AUTHOR) ; Bonaddio, Jacinta^1,2 (AUTHOR); Lawrentschuk, Nathan^1,2,3,4 (AUTHOR)

Source: Journal of Clinical Medicine. May2025, Vol. 14 Issue 10, p3580. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

A Multiparametric MRI and Baseline-Clinical-Feature-Based Dense Multimodal Fusion Artificial Intelligence (MFAI) Model to Predict Castration-Resistant Prostate Cancer Progression.

Authors : He, Dianning¹ (AUTHOR); Zhuang, Haoming² (AUTHOR); Ma, Ying^2,3 (AUTHOR)

Source: Cancers. May2025, Vol. 17 Issue 9, p1556. 17p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Safety and Efficacy of Reduced Dose of Enzalutamide in Patients with Castration-Resistant Prostate Cancer: A Systematic Review.

Authors : Belabaci, Zineddine¹ (AUTHOR); Mose, Lucas² (AUTHOR); El-Taji, Omar³ (AUTHOR)

Source: Pharmaceuticals (14248247). May2025, Vol. 18 Issue 5, p732. 12p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Integrating multimodal data to predict the progression of hormone-sensitive prostate cancer.

Authors : Lu, Xiangfu¹ (AUTHOR); Pan, Chenxi² (AUTHOR); Yao, Luhan³ (AUTHOR)

Source: Clinical Proteomics. 5/29/2025, Vol. 22 Issue 1, p1-15. 15p.

Record details

Read Online Read More Add to Saved list

Academic Journal

A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer.

Authors : Lu, Xiaolin¹ (AUTHOR); Dai, Tao² (AUTHOR); Chen, Xue² (AUTHOR)

Source: BMC Medicine. 5/9/2025, Vol. 23 Issue 1, p1-9. 9p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers.

Authors : Kwon, Whi-An¹ (AUTHOR); Joung, Jae Young² (AUTHOR)

Source: Biomolecules (2218-273X). May2025, Vol. 15 Issue 5, p625. 42p.

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Evaluating the Diagnostic Role of the Testosterone-to-Prostate-Specific Antigen Ratio in Pre-Biopsy Risk Stratification of Prostate Cancer.

Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting.

Online adaptive stereotactic body radiotherapy for localized prostate cancer in patients with lower urinary tract symptoms and/or prostate hyperplasia (X-SMILE).

Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications.

PSMA PET as a Tool for Active Surveillance of Prostate Cancer—Where Are We at?

A Multiparametric MRI and Baseline-Clinical-Feature-Based Dense Multimodal Fusion Artificial Intelligence (MFAI) Model to Predict Castration-Resistant Prostate Cancer Progression.

Safety and Efficacy of Reduced Dose of Enzalutamide in Patients with Castration-Resistant Prostate Cancer: A Systematic Review.

Integrating multimodal data to predict the progression of hormone-sensitive prostate cancer.

A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer.

Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers.

Contact

Follow us